Thus, our study suggests that pharmacological inhibition of the β-adrenoceptor/renin/Ang pathway is beneficial to prevent the development of DPN, in addition to diabetic nephropathy and cardiomyopathy3,31,32, in T2DM patients. This evidence concerns the gene REN and type 2 diabetes mellitus.